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Photodynamic therapy (PDT) dosimetric tools are crucial for treatment planning and noninvasive monitoring by
means of fluorescence. Present approaches consider usually a 1D problem, a simple photochemical process, or
a spatially homogeneous photosensitizer. In this work, a radially resolved superficial photosensitizer fluorescence
and 3D photochemical time-dependent PDTmodel are presented. The model provides a time-dependent estimation
of tissue fluorescence and the photosensitizer and singlet oxygen 3D concentrations. The model is applied to a basal
cell carcinoma treated by Metvix topical photosensitizer protocol. The analysis shows the potentiality in treatment
planning and monitoring. The fluorescence results are in agreement with previous measurements. © 2014 Optical
Society of America
OCIS codes: (170.5180) Photodynamic therapy; (170.3660) Light propagation in tissues; (260.2510) Fluorescence;
(260.5130) Photochemistry.
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Nowadays photodynamic therapy (PDT) dosimetry re-
mains a challenging problem [1]. Although different dosi-
metric factors have been studied, the photodynamic
process complexity and the dynamic variation of the
parameters involved make this goal difficult to achieve
[2]. Accurate predictive models would enable an optimal
treatment outcome, based on a personalized treatment
planning and monitoring, including a decrease in the
tumor recurrence rate after PDT treatment.
A thorough PDT model must take into account several
underlying phenomena, occurring at different spatial
and temporal scales. The most relevant ones are the
optical propagation in tissue, the photosensitizer
spatial-temporal distribution, and the photochemical in-
teraction among the excitation light, the photosensitizer
and the tissue oxygen [2]. Most of the recent models are
focused on the use of the aminolevulinic acid (ALA) in
dermatology, and include approaches for these basic
phenomena, as well as the protoporphyrin IX (PpIX) total
superficial fluorescence [3]. A recently reported model
studied the relationship between a photosensitizer
fluorescence-based dosimetry and singlet oxygen distri-
bution during treatment [4]. This model is 1D and was
applied to only healthy skin, so it does not consider
the photodynamic process radial dependence, nor the
influence of the pathological tissue optical properties.
A very recent work proposed the use of photosensitizer
fluorescence to estimate the local oxygen concentration
[5]. This work proves that the steady-state fluorescence
signal of AlPcS4 depends on oxygen concentration and
optical fluence rate. The analysis is constrained to a
simple step function fluence rate, from which molecular
components involved in photochemical interaction are
evaluated. As a consequence, it does not consider the
geometry or the optical properties of the biological
medium. Both issues have been formerly included in
a Monte Carlo (MC) method to calculate the PpIX
fluorescence and singlet oxygen production during
treatment in superficial basal cell carcinomas (BCC) [6].
However, this work did not consider the inhomogeneous
distribution of the photosensitizer, the PDT induced
oxygen reduction, or the radial dependence of singlet
oxygen.
The constraints of previous works make it difficult to
get an accurate quantification of the whole photody-
namic process in a real clinical setting, including a
thorough evaluation of the fluorescence measured at
the tumor surface. This work presents a 3D model for
PDT, able to predict the temporal evolution of the super-
ficial radially resolved photosensitizer fluorescence of a
skin tumor. It also provides the radially and depth-
resolved photosensitizer and singlet oxygen concentra-
tions. These components are of great interest to estimate
the treatment progress and 1O2-mediated oxidative dam-
age. The model has been applied to a BCC, taking into
account the current Metvix protocol specifications [7],
to show the potential use in the clinical practice. The
results are in agreement with previous measurements.
Light distribution in a 3D tissue can be obtained by
means of the radiation transport theory (RTT) [Eq. (1),
where Ir; ŝ is the specific intensity and pŝ · ŝ0 is the
scattering phase function]. The MC method by Wang
et al. [8] was employed to solve the equation. A superfi-
cial BCC of 3 mm depth, lying on healthy tissue, was
considered. The optical properties of a BCC tumor at
the excitation wavelength (635 nm) are μa  1.5 cm−1,
μs  104.76 cm−1, g  0.79, and n  1.5 [9]. A top hat
laser beam with a 0.3 cm radius, perpendicular to the
tissue sample, was used to deliver an irradiance of
100 mW∕cm2:





pŝ · ŝ0Ir; ŝ0dΩ0:
(1)
The inhomogeneous spatial-temporal distribution of
the topical photosensitizer precursor methyl aminolevu-
linate (MAL) in the tissue and the consequent
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endogenously produced photosensitizer (PpIX) during
an incubation period of 3 h were calculated from Fick’s
law [10]. The temporal evolution of the photosensitizer
precursor concentration is modeled according to
Eq. (2). MAL initial superficial concentration, M0, was
calculated taking into account the Metvix protocol spec-
ifications, mainly the precursor density and its molecular
mass. For a 1 cm radius circular lesion, M0 was set to
4.5 · 1020 cm−3. D is the diffusion coefficient, whose
common value through the epidermis and dermis is
0.69 · 10−10 m2∕s. K is the permeability of the stratum
corneum, which acts as the main diffusion barrier, and
was set to 10−6 m∕s, greater than that for healthy skin





































If the photosensitizer relaxation time is short com-
pared to its precursor diffusion time (τp ≪ t), then the
concentration of photoactive compound is proportional
to the instantaneous value of the precursor concentra-
tion and can be obtained by Eq. (3). In this equation,
εp is the conversion process yield and τa→p the relaxation
time of the photosensitizer precursor due to the genera-
tion of the photoactive compound. Here the conversion
process yield was set to 0.5, the relaxation time of the
photosensitizer to 84 ms, and the relaxation time of





The photochemical pathways during a type II PDT
process were modeled by the differential equations sys-
tem in Eqs. (4)–(9). It was first proposed by Foster et al.
[12], and later employed by others [13,14], as the basis to
describe the temporal evolution of the molecular compo-
nents involved in the photochemical interaction:
dS0
dt































1O2  P; (7)
d1O2
dt










 −kcx1O2R  U: (9)
In these equations, S0, S1, and T  are the photosen-
sitizer concentration in the ground state, singlet excited
state, and triplet excited state, respectively. 3O2 is the
oxygen concentration in ground state; 1O2 is the singlet
oxygen concentration; R is the concentration of 1O2
receptors; C is the scavengers concentration; τ1 is
the relaxation time from state S1 to S0; τ3 is the relaxa-
tion time from state T to S0; τ0 is the relaxation time from
state 1O2 to 3O2; η10 is the quantum yield of the S1 to S0
transition; η13 is the quantum yield of the S1 to T transi-
tion; η30 is the quantum yield of T transition to S0; η0 is the
quantum yield of 1O2 transition to 3O2; αs is the efficiency
factor for energy transfer from T to 3O2; kpb stands for
the biomolecular photobleaching rate; kcx is the biomo-
lecular cytotoxicity rate; ksc is the rate of reaction of 1O2
with various oxygen scavengers; ν is light speed in tissue;
ρ is the photon density; σpsa is the absorption cross-
section of S0 molecules; P is the rate of oxygen diffusion
and perfusion; and U is the cell damage repair rate. The
values to the previous parameters can be found in [11].
The stiff differential equations system was solved
by means of a differential equation solver within the
MATLAB platform. The time-resolved 3D photosensitizer
fluorescence emission at 705 nm was obtained, taking
into account the excitation photon density absorbed by
the photosensitizer molecules, and the fluorescence
quantum yield. The fluorescence power density gener-
ated can be expressed as [15]
Pf r; z; t  v · ρ · σpsa · S0:η10 · Ephotonλem ; (10)
where Ephotonλem  h · c∕λem is the photon energy at the
fluorescence emission wavelength λem, h is Planck’s con-
stant, and c is the speed of light in vacuum.
The superficial fluorescence due to the photosensitizer
molecules was calculated as the treatment progresses.
For this purpose, another MC approach was used, based
on [16]. The fluorescence escape was due to a time-
dependent spatially nonuniform fluorophore distribu-
tion. The local fluorescence sources were dynamically
updated over time and space by Eq. (10). From the spatial
3D distribution of the fluorescence sources within the tis-
sue, it is possible to obtain their contribution to the total
escaping fluorescence at tissue surface. For a particular
treatment time, the total escaping fluorescence, Jf , at a
certain superficial radial position, r, can be obtained by
the accumulation of the escaping flux produced by each
of the fluorescent power sources. The power density of
fluorescence escaping at the tissue surface is calculated
according to Eq. (11). In this equation, rs and zs are the
coordinates of the fluorescence source, ΔV is the incre-
mental volume associated to the source position, and T is
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the fluorescence transfer function, from source to
surface:





Pf rs; zx; tΔVrs; zsTrs; zs; r: (11)
Figure 1 shows the total escaping fluorescence irradi-
ance at the BCC surface as the irradiation time increases.
As expected, it decays with time as a consequence of the
PpIX photobleaching, which is higher in the superficial
zones. This fact results in higher fluorescence at the be-
ginning of treatment, coming mostly from the superficial
zones. As the treatment evolves, the potential fluores-
cence sources are located deeper, causing a pathlength
increase of photons to reach the surface and, as a con-
sequence, a decrease in the PpIX fluorescence observed
at the tissue surface. A slight increase in the fluorescence
out of the optical beam radius can be observed, which
becomes evident at approximately the halfway treatment
(t  300 s). The fluorescence increase is caused by the
scattered excitation and emission photons beyond the di-
rectly irradiated area. As it can be seen by comparing
t  60 s with t  300 s or t  600 s, this effect intensifies
as the treatment progresses, due to the increment of scat-
tering events of fluorescence photons coming from
deeper positions. These results highlight the relevance
of considering the spatial optical beam profile and the
optical properties of the target medium.
The model provides also the time- and spatially depen-
dent photosensitizer and singlet oxygen concentrations.
The photosensitizer concentration at different depths
within the tumor is shown in Fig. 2 for different temporal
instants during the irradiation period. As it can be seen by
comparing t  6 s and t  60 s, the higher photobleach-
ing in superficial zones provokes the relocation of the
fluorescence photosensitizer sources at deeper posi-
tions. This is in agreement with the previous analysis
of Fig. 1. Generated singlet oxygen concentration is de-
picted in Fig. 3. As it can be observed by comparing t 
6 s and t  60 s, the maximum concentration is reached
in deeper areas as time progresses. This concentration is
related with tumor oxidative damage. As a consequence,
the adequate and accurate estimation of this concentra-
tion is crucial for treatment planning.
Figures 4 and 5 show the relevance of the photody-
namic process radial dependence. For a particular depth
within the tumor, the time-dependent photosensitizer
degradation (Fig. 4) and singlet oxygen concentration
(Fig. 5) are evidently correlated with the radius of the
optical beam (0.3 cm). The areas with increased concen-
tration of singlet oxygen will be more affected by the ox-
idative damage. As it is shown in Figs. 4 and 5, this
cytotoxic effect extends beyond the optical beam radius,
particularly for longer times (t  600 s), due to the scat-
tering of the biological tissue. Again it is shown that a
complete PDT analysis should include the 3D optical dis-
tribution, considering the optical source profile and the
tissue optical properties. This would allow the avoidance
of cytotoxic effects out of the area of the tumor.
The total normalized PpIX fluorescence signal ob-
tained by means of the proposed PDT model, applied to
a BCC tumor, was represented as a function of treatment




























Fig. 1. Total superficial fluorescence irradiance [W∕cm2] from
BCC as a function of radial position, for different irradiation
times.


























Fig. 2. Photosensitizer concentration [cm−3] as a function of
depth within the tumor, at different treatment times for
r  1.125 mm.




















Fig. 3. Singlet oxygen concentration [cm−3] as a function of
depth within the tumor at different treatment times for
r  1.125 mm.
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time in Fig. 6 (red line). As shown, the model is in good
agreement with previously reported measurements in
patients affected by the same type of nonmelanoma skin
cancer [17], Fig. 6 (blue line). The difference between
the blue and red lines in Fig. 6 is due to the distinct
irradiance of the clinical Metvix protocol in our model,
100 mW∕cm2 and in the measurements in [17],
150 mW∕cm2. Nevertheless, this difference indicates that
a greater amount of irradiation (150 mW∕cm2) induces a
fluorescence irradiance increase (Fig. 6, blue line), as ex-
pected. This fact demonstrates the accuracy of the model
to direct noninvasive fluorescence measurements.
The presented model allows the prediction and inter-
pretation of the superficial radially resolved photosensi-
tizer fluorescence. The model also permits us to relate
this information to the spatial–temporal evolution of the
key molecular components involved in the development
and the outcome of treatment such as the photosensitizer
or singlet oxygen concentrations. Several dosimetric
parameters can be varied, including the optical source
radius or irradiance, the photosensitizer type, the
photochemical interaction parameters or the biological
media geometry and optical properties. It could be
employed as a personalized planning and noninvasive
monitoring tool in the dermatooncologic clinical practice
in order to optimize PDT treatment and to avoid tumor
recurrence.
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Fig. 4. Photosensitizer concentration [cm−3] as a function of
the radial component at different treatment times for
z  1.55 mm.























Fig. 5. Singlet oxygen concentration [cm−3] as a function of
the radial component at different treatment times for
z  1.55 mm.

























Fig. 6. Average normalized total PpIX fluorescence obtained
with the MAL-PDT model proposed at 100 mW∕cm2 (red line),
and with clinical results at 150 mW∕cm2 [17] (blue line), as a
function of treatment time.
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